Fig. 3From: Unique depot formed by an oil based vaccine facilitates active antigen uptake and provides effective tumour controlProfiles of peptide release determined by the dialysis tube method comparing DPX-Survivac, w/o-Survivac, and AC-Survivac and evaluating DPX-Survivac over 1 month. Peptide antigens are retained in the DPX formulation when compared with a water-in-oil formulation and an aqueous control. Peptide antigens remain in the DPX formulation. a-g) Peptide release over 24 h, h) Peptide release over 1 monthBack to article page